Corcept Therapeutics
Payal Shirsat is a seasoned professional in the field of clinical pharmacology and pharmacokinetics, currently serving as Senior Manager at Corcept Therapeutics since January 2022. Prior to this role, Payal held various positions at Theravance Biopharma US, Inc. from May 2014 to January 2022, including Senior Research Manager and Research Manager II, specializing in DMPK. Previous experience includes roles at Nektar Therapeutics, ARYx Therapeutics, XenoPort, and Cellegy Pharmaceuticals Inc., demonstrating a strong background in research and development. Payal Shirsat holds a Master's degree in Zoology from the University of Mumbai and a Bachelor's degree in Zoology from Delhi University.
This person is not in any teams
Corcept Therapeutics
4 followers
Corcept Therapeutics Inc. is a pharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncologic disorders.